Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Dexamethasone for Relapsed Multiple Myeloma
NCT00335348Phase 2Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Jun 2006
- Primary completion
- Jul 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Peter MacCallum Cancer Centre. Started Jun 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00335348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335348.